Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome

Medicine

Volumn 75, Issue 4, 1996, Pages 185-194

  Becker, Klaus ^a   Jablonowski, Helmut ^a   Häussinger, Dieter ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; PYRIMETHAMINE; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CALCIFICATION; CLINICAL ARTICLE; CLINICAL FEATURE; CRYSTALLURIA; ENCEPHALOMYELITIS; FEMALE; HUMAN; KIDNEY CONCENTRATING CAPACITY; KIDNEY DISEASE; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; TOXOPLASMA GONDII;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ENCEPHALITIS; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROGNOSIS; SULFADIAZINE; TOXOPLASMOSIS;

EID: 0029777344     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199607000-00002     Document Type: Article

References (56)

1. Abeshouse BS, Tankin LH. Renal complications of sulfonamide therapy. J Urol 56: 658-87, 1946.
2. Anonymous. Sulfadiazine. In: Budavari S, O'Neil MJ, Smith A, Heckelman PE, eds. The Merck Index. An encyclopedia of chemicals, drugs, and biologicals. 11th ed. Rahway, NJ: Merck, p. 1404, 1989.
3. Appel GB, Neu HC. The nephrotoxicity of antimicrobial agents. N Engl J Med 296: 784-87, 1977.
4. Bressollette L, Carlhant D, Bellein V, Morand C, Mottier D, Riche C. Cristallurie induite par la sulfadiazine chez un sidéen. Therapie 49: 154-55, 1994.
5. Buchanan N. Sulphamethoxazole, hypoalbuminaemia, crystalluria, and renal failure. Br Med J 2: 172, 1978.
6. Carbone LG, Bendixen B, Appel GB. Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome. Am J Kidney Dis 12: 72-75, 1988.
7. Christin S, Baumelou A, Bahri S, Ben Hmida M, Deray G, Jacobs C. Acute renal failure due to sulfadiazine in patients with AIDS. Nephron 55: 233-34, 1990.
8. Corbella X, Mascaró J, Santín M, Carratalà J. Insuflciencia renal aguda por sulfadiazina en el tratamiento de una toxoplasmosis cerebral. Rev Clin Espan 190: 330-31, 1992.
9. Dannemann B, McCutchan JA, Israelski D, Antoniskis D, Leport C, Luft B, Nussbaum J, Clumeck N, Mortal P, Chiu J, VUde J-L, Orellana M, Feigal D, Bartok A, Heseltine P, Leedom J, Remington J. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med 116: 33-43, 1992.
10. De Jaureguiberry JP, Reboul P, Vey N, Jaubert D. Insuffisance rénale aiguë par cristallurie à la sulfadiazine au cours du SIDA. Résurgence d' une complication iatrogène historique. Ann Med Intern 143: 218-19, 1992.
11. Dorfman LE, Smith JP. Sulfonamide crystalluria. A forgotten disease. J Urol 104: 482-83, 1970.
12. Dowling HF, Lepper MH. Toxic reactions following therapy with sulfapyridine, sulfathiazole and sulfadiazine. JAMA 121: 1190-94, 1943.
13. Fariñas MC, Echevarria S, Sampedro I, Gonzalez A, Pérez del Molino A, González-Macías J. Renal failure due to sulphadiazine in AIDS patients with cerebral toxoplasmosis. J Intern Med 233: 365-67, 1993.
14. Finland M, Strauss E, Peterson OL. Sulfadiazine: Therapeutic evaluation and toxic effects on four hundred and forty-six patients. JAMA 116: 2641-47, 1941.
15. Flippin HF, Reinhold JG. An evaluation of sulfonamide mixtures and various adjuvants for control of sulfonamide crystalluria. Ann Intern Med 25: 433-43, 1946.
16. Flippin HF, Rose SB, Schwarte L, Domm AH. Sulfadiazine and sulfathiazole in the treatment of pneumococcic pneumonia. A progress report on 200 cases. Am J Med Sci 201: 585-92, 1941.
17. Furrer H, von Overbeck J, Jaeger P, Hess B. Sulfadiazin-Nephrolithiasis und Nephropathie. Schweiz Med Wochenschr 124: 2100-2105, 1994.
18. Goadsby PJ, Donaghy AJ, Lloyd AR, Wakefield D. Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure. Ann Intern Med 107: 783-84, 1987.
19. Haverkos HW. Assessment of therapy for toxoplasma encephalitis. The TE study group. Am J Med 82: 907-14, 1987.
20. Hein R, Brunkhorst R, Thon WF, Schedel I, Schmidt RE. Symptomatic sulfadiazine crystalluria in AIDS patients: A report of two cases. Clin Nephrol 39: 254-56, 1993.
21. Jeck HS, Orkin L. Toxic renal reactions following the use of sulfadiazine. Urology 49: 290-301, 1943.
22. Jensen OJ, Fox CL. Hydrogen ion concentration and the solubility of sulfonamides in urine: The relation to renal precipitation. J Urol 49: 334-39, 1943.
23. Keitzer WA, Campbell JA. Renal complications of sulladiazine. JAMA 119: 701-03, 1943.
24. Kronawitter U, Jakob K, Zoller WG, Rauh G, Goebel F-D. Acute renal failure caused by sulphadiazine stones: Complication of toxoplasmosis treatment in a patient with AIDS. Dtsch Med Wschr 118: 1683-86, 1993.
25. Kutscher AH, Lane SL, Segall R. The clinical toxicity of antibiotics and sulfonamides. A comparative review of the literature based on 104672 cases treated systemically. J Allergy 25: 135-50, 1954.
26. Lehr D, Antopol W. Specific morphology of crystals appearing in the urine during administration of sulfanilamide derivatives. Am J Clin Pathol 12: 200-209, 1942.
27. Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde J-L. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Am J Med 84: 94-100, 1988.
28. Louria AL, Solomon C. Complete anuria caused by sulfadiazine. JAMA 120: 1354-56, 1942.
29. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM, Bourland DD III, Uttamchandani R, Fuhrer J, Jacobson J, Mortal P, Vilde J-L, Remington JS. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 329: 995-1000, 1993.
30. Mandell GL, Sande MA. Antimicrobial agents. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. 8th ed. New York: McGraw-Hill, p. 1047-57, 1990.
31. Marques LPJ, Madeira EPQ, Santos OR. Renal alterations induced by sulfadiazine therapy in an AIDS patients. Clin Nephrol 42: 68-69, 1994.
32. Marques LPJ, Silva MT, Madeira EPQ, Santos OR. Obstructive renal failure due to therapy with sulfadiazine in an AIDS patient. Nephron 62: 361, 1992.
33. Miller MA, Gallicano K, Dascal A, Mendelson J. Sulfadiazine urolithiasis during antitoxoplasma therapy. Drug Invest 5: 334-37, 1993.
34. Molina J-M, Belenfant X, Doco-Lecompte T, Idatte J-M, Modai J. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. AIDS 5: 587-89, 1991.
35. Murphy FD, Kuzma JF, Polley TZ, Grill J. Clinicopathologic studies of renal damage due to sulfonamide compounds. A report of fourteen cases. Arch Intern Med 73: 433-43, 1944.
36. Nissen NI, Aagaard K, Flindt-Hansen E. Sulfonamide hematuria. Frequency of injury to the urinary tract as estimated on the basis of 6084 cases treated with different sulfonamide preparations. Acta Med Scand 138: 301-15, 1950.
37. Oster S, Hutchison F, McCabe R. Resolution of acute renal failure in toxoplasmic encephalitis despite continuance of sulfadiazine. Rev Infect Dis 12: 618-20, 1990.
38. Owens CJ, Yarbrough DR III, Brackett NC Jr. Nephrotic syndrome following topically applied sulfadiazine silver therapy. Arch Intern Med 134: 332-35, 1974.
39. Peh CA, Kimber TE, Shaw DR, Clarkson AR. Acute renal failure due to sulphadiazine in a patient with acquired immunodeficiency syndrome (AIDS). Aust NZ J Med 25: 58, 1995.
40. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 327: 1643-48, 1992.
41. Portoles J, Torralbo A, Prats D, Blanco J, Barrientos A. Acute renal failure and sulphadiazine crystalluria in kidney transplant. Nephrol Dial Transplant 9: 180-81, 1994.
42. 4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS). Clin Chim Acta 230: 221-24, 1994.
43. Prien EL. The mechanism of renal complications in sulfonamide therapy. N Engl J Med 232: 63-68, 1945.
44. Renold C, Sugar A, Chave JP, Perrin L, Delavelle J, Pizzolato G, Burkhard P, Gabriel V, Hirschel B. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore) 71: 224-39, 1992.
45. Rivera M, Liaño F, Fortún J, Fernández-Lucas M, Ortuño J. Sulfadiazine-induced obstructive renal failure in a patient with acquired immunodeficiency syndrome (AIDS). Nephrol Dial Transplant 8: 1183-84, 1993.
46. Robson M, Levi J, Dolberg L, Rosenfeld JB. Acute tubulo-interstitial nephritis following sulfadiazine therapy. Isr J Med Sci 6: 561-66, 1970.
47. Sahai J, Heimberger T, Collins K, Kaplowitz L, Polk R. Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome. A reminder. Am J Med 84: 791-92, 1988.
48. Sasson JP, Dratch PL, Shortsleeve MJ. Renal US findings in sulfadiazine-induced crystalluria. Radiology 185: 739-40, 1992.
49. Satterthwaite RW. Sulfadiazine reactions: Their frequency and treatment in urological cases. J Urol 49: 302-15, 1943.
50. Simon DI, Brosius FC, Rothstein DM. Sulfadiazine crystalluria revisited. The treatment of toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. Arch Intern Med 150: 2379-84, 1990.
51. Ventura MG, Wybran J, Farber CM. Sulfadiazine revisited. J Infect Dis 160: 566-57, 1989.
52. Weinstein L, Madoff MA, Samet CM. The sulfonamides. N Engl J Med 263; 952-57, 1960.
53. Wheeler C, Plummer N. Sulfadiazine and sodium sulfadiazine: a comparison of certain of their clinical and pharmacologic values. Ann Intern Med 16: 269-85, 1942.
54. Winterbom MH, Mann JR. Anuria due to sulphadiazine. Arch Dis Child 48: 915-17, 1973.
55. Zide HA. Renal complications of sulfonamide administration; report of reactions from sulfathiazole and sulfadiazine. J Urol 52: 275-82, 1944.
56. Zubizarreta García J, Ayensa Deán C, Aldamiz-Echebarría San Sebastián M, Ruiz de Gauna López de Heredia R. Insuficiencia renal aguda secundaria a cristaluria por sulfadiazina. Med Clin (Barc) 102: 40-41, 1994.